JP2011516477A5 - - Google Patents

Download PDF

Info

Publication number
JP2011516477A5
JP2011516477A5 JP2011502992A JP2011502992A JP2011516477A5 JP 2011516477 A5 JP2011516477 A5 JP 2011516477A5 JP 2011502992 A JP2011502992 A JP 2011502992A JP 2011502992 A JP2011502992 A JP 2011502992A JP 2011516477 A5 JP2011516477 A5 JP 2011516477A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
pharmaceutically acceptable
acceptable salt
dry eye
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011502992A
Other languages
English (en)
Japanese (ja)
Other versions
JP5480242B2 (ja
JP2011516477A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/002121 external-priority patent/WO2009123761A1/en
Publication of JP2011516477A publication Critical patent/JP2011516477A/ja
Publication of JP2011516477A5 publication Critical patent/JP2011516477A5/ja
Application granted granted Critical
Publication of JP5480242B2 publication Critical patent/JP5480242B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011502992A 2008-04-04 2009-04-03 ドライアイ治療用βターンペプチド模倣環式化合物 Active JP5480242B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12303608P 2008-04-04 2008-04-04
US61/123,036 2008-04-04
US20887309P 2009-02-27 2009-02-27
US61/208,873 2009-02-27
PCT/US2009/002121 WO2009123761A1 (en) 2008-04-04 2009-04-03 Beta-turn peptidomimetic cyclic compounds for treating dry eye

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014025563A Division JP5870348B2 (ja) 2008-04-04 2014-02-13 ドライアイ治療用βターンペプチド模倣環式化合物

Publications (3)

Publication Number Publication Date
JP2011516477A JP2011516477A (ja) 2011-05-26
JP2011516477A5 true JP2011516477A5 (https=) 2012-05-24
JP5480242B2 JP5480242B2 (ja) 2014-04-23

Family

ID=40897413

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011502992A Active JP5480242B2 (ja) 2008-04-04 2009-04-03 ドライアイ治療用βターンペプチド模倣環式化合物
JP2014025563A Active JP5870348B2 (ja) 2008-04-04 2014-02-13 ドライアイ治療用βターンペプチド模倣環式化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014025563A Active JP5870348B2 (ja) 2008-04-04 2014-02-13 ドライアイ治療用βターンペプチド模倣環式化合物

Country Status (9)

Country Link
US (4) US8293713B2 (https=)
EP (1) EP2271337B1 (https=)
JP (2) JP5480242B2 (https=)
KR (1) KR101565185B1 (https=)
CN (1) CN102046166B (https=)
AU (1) AU2009232352B2 (https=)
CA (1) CA2720141C (https=)
ES (1) ES2521515T3 (https=)
WO (1) WO2009123761A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2521515T3 (es) * 2008-04-04 2014-11-12 Mimetogen Pharmaceuticals Inc. Compuestos cíclicos peptidomiméticos con giro beta para tratar el ojo seco
US9115179B2 (en) * 2012-06-22 2015-08-25 Mimetogen Pharmaceuticals Inc. Synthesis of beta-turn peptidomimetic cyclic compounds
KR20150004652A (ko) 2013-07-03 2015-01-13 삼성디스플레이 주식회사 표시 패널, 이를 포함하는 표시 장치 및 이를 이용하는 영상 표시 방법
JP6267003B2 (ja) * 2014-02-27 2018-01-24 参天製薬株式会社 ジクアホソルまたはその塩およびレバミピドまたはその塩を組み合わせたことを特徴とする涙液分泌促進剤
CN113230021A (zh) 2015-01-12 2021-08-10 科达莱昂治疗公司 微滴递送设备和方法
CN107530509A (zh) 2015-04-10 2018-01-02 科达莱昂治疗公司 具有可替换安瓿的压电分配器
AU2016290654C1 (en) * 2015-07-09 2021-11-11 Mimetogen Pharmaceuticals, Inc. Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts
KR101718733B1 (ko) 2015-08-21 2017-03-22 국제약품 주식회사 레바미피드의 가용화 방법 및 이에 의해 제조된 안구건조증 치료용 액제
WO2017152027A1 (en) 2016-03-04 2017-09-08 Rynerson James M Method of treating an eye disorder by inhibiting or disrupting bacterial biofilm formation
CN109906120A (zh) 2017-01-20 2019-06-18 科达莱昂治疗公司 压电流体分配器
WO2019113483A1 (en) 2017-12-08 2019-06-13 Kedalion Therapeutics, Inc. Fluid delivery alignment system
CN110092799B (zh) * 2018-01-29 2021-11-12 广州丹康医药生物有限公司 一种环状化合物、其制备方法和应用
US12350194B1 (en) 2018-04-12 2025-07-08 Bausch + Lomb Ireland Limited Topical ocular delivery of fluids with controlled mass dosing and wireless communication
US20190314197A1 (en) 2018-04-12 2019-10-17 Kedalion Therapeutics, Inc. Topical Ocular Delivery Methods and Devices for Use in the Same
WO2020010116A1 (en) 2018-07-03 2020-01-09 Kedalion Therapeutics, Inc. Topical ocular delivery devices and methods for using the same
US11679028B2 (en) 2019-03-06 2023-06-20 Novartis Ag Multi-dose ocular fluid delivery system
US12097145B2 (en) 2019-03-06 2024-09-24 Bausch + Lomb Ireland Limited Vented multi-dose ocular fluid delivery system
US12496218B1 (en) 2019-11-12 2025-12-16 Bausch + Lomb Ireland Limited Fractionated topical ocular drug delivery methods and devices for use in the same
US12290472B2 (en) 2020-04-17 2025-05-06 Bausch + Lomb Ireland Limited Hydrodynamically actuated preservative free dispensing system
US11938057B2 (en) 2020-04-17 2024-03-26 Bausch + Lomb Ireland Limited Hydrodynamically actuated preservative free dispensing system
EP4120973A4 (en) 2020-04-17 2024-04-17 Bausch + Lomb Ireland Limited Hydrodynamically actuated preservative free dispensing system having a collapsible liquid reservoir
CN115768384A (zh) 2020-04-17 2023-03-07 科达隆治疗公司 流体动力致动的不含防腐剂分配系统
WO2022256394A2 (en) * 2021-06-02 2022-12-08 The Texas A&M University System Selective small molecule agonists and partial agonists of trk receptors
WO2023069255A1 (en) * 2021-10-20 2023-04-27 Stealth Biotherapeutics Inc. Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions
WO2023069549A1 (en) * 2021-10-20 2023-04-27 Stealth Biotherapeutics Inc. Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8917217D0 (en) * 1989-07-27 1989-09-13 Smith & Nephew Ophthalmic compositions
US5545617A (en) 1993-11-12 1996-08-13 The Schepens Eye Research Institute, Inc. Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion
WO1999032135A1 (en) * 1997-12-22 1999-07-01 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
JP2001064198A (ja) 1999-08-24 2001-03-13 Teika Seiyaku Kk 角膜疾患治療剤
ATE340571T1 (de) * 2000-01-18 2006-10-15 Univ Mcgill Pharmazeutische zubereitungen enthaltend beta- turn peptidomimetische zyklische substanzen
EP1734052B1 (en) 2005-06-13 2009-02-18 Primm S.R.L. Heterodimeric peptide compounds displaying NGF activity and their use to treat neurodegenerative disorders
EP1921087A1 (en) 2006-11-10 2008-05-14 Primm S.R.L. Process for the preparation of cyclic peptides
JP5576659B2 (ja) * 2006-12-05 2014-08-20 ザ ロイヤル インスティテューション フォー ジ アドバンスメント オブ ラーニング/ マギル ユニバーシティ Trkレセプター調節因子の使用方法
ES2521515T3 (es) * 2008-04-04 2014-11-12 Mimetogen Pharmaceuticals Inc. Compuestos cíclicos peptidomiméticos con giro beta para tratar el ojo seco
CA2752891C (en) * 2009-02-27 2018-08-21 Mimetogen Pharmaceuticals Inc. Peptidomimetic cyclic compounds for treating retinitis pigmentosa
US9115179B2 (en) * 2012-06-22 2015-08-25 Mimetogen Pharmaceuticals Inc. Synthesis of beta-turn peptidomimetic cyclic compounds

Similar Documents

Publication Publication Date Title
JP2011516477A5 (https=)
JP2013520405A5 (https=)
JP2013500977A5 (https=)
FI3811943T3 (fi) Yhdiste käytettäväksi silmäsairauksien hoidossa
JP2013534527A5 (https=)
HRP20240168T1 (hr) Kombinacije dolutegravira i lamivudina za liječenje hiv infekcije
JP2015501783A5 (https=)
BR112014008789A2 (pt) prevenção e tratamento de condições oculares
RU2014120792A (ru) Способ лечения стромальных опухолей желудочно-кишечного тракта
JP2013519675A5 (https=)
NZ602510A (en) Treatment of lupus nephritis using laquinimod
UA104489C2 (uk) Сполуки для лікування дисліпідемії та споріднених хвороб
JP2016528301A5 (https=)
BR112013032122A2 (pt) liberação modificada de 4-metil-3-[[4-(3-piridinil)-2-pirimidinil]amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)fenil] benzamida solubilizada usando ácidos orgânicos
RU2017139870A (ru) Новые агонисты npr-b
RU2017114352A (ru) АНТАГОНИСТЫ ИНТЕГРИНА ανβ6
HRP20171648T1 (hr) Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze
NZ600544A (en) Compositions and methods for the treatment of angiogenesis-related eye diseases
JP2015516419A5 (https=)
JP2011046708A5 (https=)
RU2016112257A (ru) Композиция для лечения гипертензии и/или фиброза
BR112014009165A8 (pt) sal e uso médico
EA201490166A1 (ru) Фторированные арилалкиламинокарбоксамидные производные
EA201270653A1 (ru) Антагонист dpи его применение
JP2013523739A5 (https=)